Page last updated: 2024-09-03

lestaurtinib and Carcinogenesis

lestaurtinib has been researched along with Carcinogenesis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, C; Jo, HJ; Kim, HR; Kim, HS; Kim, JI; Kwon, CH; Lee, JH; Lee, JS; Oh, N; Park, DY; Park, E; Park, HD; Park, J; Park, OK; Seo, JS; Shin, E; Shin, JY	1

Other Studies

1 other study(ies) available for lestaurtinib and Carcinogenesis

Article	Year
NTRK1 fusions for the therapeutic intervention of Korean patients with colon cancer. Oncotarget, 2016, 02-16, Volume: 7, Issue:7 Topics: Aged; Animals; Carbazoles; Carcinogenesis; Case-Control Studies; Colonic Neoplasms; Crizotinib; Female; Follow-Up Studies; Furans; Gene Fusion; High-Throughput Nucleotide Sequencing; Humans; Immunoenzyme Techniques; In Situ Hybridization, Fluorescence; Lamin Type A; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Staging; Oncogene Proteins, Fusion; Prognosis; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Real-Time Polymerase Chain Reaction; Receptor, trkA; Republic of Korea; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Tropomyosin; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2016

Article

Year

NTRK1 fusions for the therapeutic intervention of Korean patients with colon cancer.

Oncotarget, 2016, 02-16, Volume: 7, Issue:7

Topics: Aged; Animals; Carbazoles; Carcinogenesis; Case-Control Studies; Colonic Neoplasms; Crizotinib; Female; Follow-Up Studies; Furans; Gene Fusion; High-Throughput Nucleotide Sequencing; Humans; Immunoenzyme Techniques; In Situ Hybridization, Fluorescence; Lamin Type A; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Staging; Oncogene Proteins, Fusion; Prognosis; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Real-Time Polymerase Chain Reaction; Receptor, trkA; Republic of Korea; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Tropomyosin; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2016